Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub‐analysis of Hokkaido‐ TZP study data

Journal of Diabetes Investigation 2026 Open access

Read full text
Authors: Tomoe Abe, Fumika Maruyama, Eisuke Nishikawa, Miki Ito, Yukie Miyano, Hiroki Yamagata, Taiga Sasaki, Hidemitsu Sakagami, Akinobu Nakamura, Hiroshi Nomoto, the Hokkaido‐TZP Study Group
DOI: 10.1111/jdi.70355
Cited by: 1
References: 11

Abstract

ABSTRACT Although tirzepatide efficaciously reduces glucose concentrations and weight, phase 3 trials evaluated patients with a body mass index (BMI) ≥23 kg/m 2 . Consequently, clinical evidence in patients with type 2 diabetes but no obesity, common in Asia, is insufficient. In this secondary analysis of the multicentre, real‐world Hokkaido‐TZP study, we evaluated 107 Japanese patients with T2D and BMI

Fields of Study & Subjects

Diabetes Cardiovascular Risks and Lipoproteins Regulation of Appetite and Obesity Bariatric Surgery and Outcomes

Publication details

Journal / source
Journal of Diabetes Investigation
Publisher
Wiley
Volume
17
Issue
8
Pages
1304–1309
Publication date
14 June 2026
Language
EN